Literature DB >> 29565698

Orbital and peri-orbital amyloidosis: a report of four cases.

Ramón Medel Jiménez1, Juan C Sánchez España1, Luz M Vasquez1, Alejandra Tapia Bahamondes1, Max Rondón1, Treserra Francesc2, Eva Ayala Barroso1.   

Abstract

Our objective was to describe our experience with orbital amyloidosis, and illustrate the different forms of presentation. This was a retrospective case series of four patients with biopsy-proven orbital amyloi- dosis, over the period from 2014 to 2016. We describe its diagnostic and clinical characteristics, management and systemic study. The series comprised three women and one man of mean age 52 ± 9.4 years. Affected sites were the lacrimal gland, tarsal conjunctiva, lacrimal sac and orbit. In three of the four patients, calcifications were observed. Three patients had associated ptosis. The patient with orbital involvement suffered an unusual vascular complication during surgery and systemic disease was detected. Management included debulking and complete resection of the lesion. In conclusion, orbital amyloidosis presents as a wide variety of forms. Its diagnosis is biopsy-based. Calcifications in biopsy specimens or images should raise suspicion of amyloidosis. It is important to always check for systemic amyloidosis.

Entities:  

Keywords:  Amyloidosis; eyelids; lacrimal gland; orbit

Mesh:

Year:  2018        PMID: 29565698     DOI: 10.1080/01676830.2018.1449868

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  2 in total

1.  Rare presentations of primary amyloidosis as ptosis: a case report.

Authors:  Peng-Hsuan Lee; I-Chuang Liao; Wan-Ju Annabelle Lee
Journal:  BMC Ophthalmol       Date:  2022-01-29       Impact factor: 2.209

Review 2.  Ocular Involvement in Hereditary Amyloidosis.

Authors:  Angelo Maria Minnella; Roberta Rissotto; Elena Antoniazzi; Marco Di Girolamo; Marco Luigetti; Martina Maceroni; Daniela Bacherini; Benedetto Falsini; Stanislao Rizzo; Laura Obici
Journal:  Genes (Basel)       Date:  2021-06-22       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.